Hengrui Retains Top Spot in 2026 China Pharmaceutical Innovation and Invention Index
Hengrui ranks first in both the China Pharmaceutical Innovation and Invention Indices for the second consecutive year. Download the full
Insights
2026 China Pharmaceutical Innovation & Invention Index
The 2026 China Pharmaceutical Innovation and Invention Index highlights the pharmaceutical companies and emerging innovators shaping the next phase of
ESMO 2026 Preview: Key studies that could fundamentally change the oncology landscape.
In this episode of the IDEA Collider podcast, Alex Gray, Chief Medical Officer at SAI & IDEA Pharma, John Barry,
Biotech Disruptive Pioneers Award – 2027
The first biotech recognition program focused on companies with the potential to change how pharma operates, not just discovering or
AI-Driven Pharma Market Research: Synthetic Users – with Kwame Ferreira & Rebecca Gould
Welcome back to the IDEA Collider podcast. In this episode, host Rick Ritacco sits down with Kwame Ferreira, Founder of
The Modern Patient Experience
How AI and expanded stakeholder perspectives are transforming rare disease patient journey research. Download the report to learn:
The Keytruda Blueprint: Alex Gray, David Radwaner, and Tom Brockbank on the IO Revolution: Part II
Welcome back to the IDEA Collider podcast. In this second instalment of our future of immuno-oncology series, Alex Gray is
Why the ATU needs to evolve with the brand
Steve Wakefield leads the Quantitative Center of Excellence at Fulcrum Research, part of SAI. With more than 25 years of
Stability and Flexibility: Transforming your ATU tracker into an adaptive learning system
Your market changes – your ATU should change, too At Fulcrum Research, we transform your ATU into an adaptive learning
Five Biotech Milestones – Lab to Success
Developing a molecule from lab to patients requires more than 1,000 decisions, made right and at the right time. However, the